The investment will support the launch of NATLEAN in January 2027 and expand Metabolize's portfolio of proprietary products powered by Precision Metabolite™ Technology.

此次投资将支持NATLEAN于2027年1月上市，并扩充Metabolize公司基于Precision Metabolite™技术的自有产品组合。

SAN FRANCISCO

旧金山

,

，

Oct. 15, 2026

2026年10月15日

/PRNewswire/ -- Metabolize, a science-first consumer health company built on Stanford Medicine-originated research, today announced the completion of its $3.2 million seed financing led by Astanor, with participation from Maia Ventures, LongGame Venture and SOSV. The investment will accelerate commercialization of the company's Precision Metabolite™ Technology while supporting continued investment in the development, validation and manufacturing of its metabolic health products..

/美通社/ -- Metabolize 是一家秉持科学优先理念的消费者健康公司，其技术源于斯坦福大学医学院的研究。该公司今日宣布完成由 Astanor 领投、Maia Ventures、LongGame Venture 和 SOSV 参与的 320 万美元种子轮融资。这笔投资将加速公司 Precision Metabolite™ 技术的商业化进程，同时支持其在代谢健康产品的开发、验证和生产方面的持续投入。

Continue Reading

继续阅读

Founded in 2024 by Dr. Morris Laster and Gideon Meir, Metabolize develops Precision Metabolite™ Technology based on naturally occurring compounds with defined biological roles identified through research led by Jonathan Long, PhD, associate professor of pathology at Stanford Medicine. Through an exclusive license to Stanford-originated intellectual property, the company is translating these patent-protected discoveries into a portfolio of consumer metabolic health products designed to work with the body's natural biology..

Metabolize 由 Morris Laster 博士和 Gideon Meir 于 2024 年创立，致力于开发 Precision Metabolite™ 技术。该技术基于具有明确生物学作用的天然化合物，这些化合物是通过斯坦福医学院病理学副教授 Jonathan Long 博士领导的研究发现的。通过获得源自斯坦福大学的知识产权的独家许可，该公司正将这些受专利保护的发现转化为一系列消费者代谢健康产品，旨在与人体自然生理机制协同作用。

What comes after GLP-1s? Metabolize lands seed funding to turn Stanford discoveries into a new era of metabolic health.

GLP-1 之后是什么？Metabolize 获得种子轮融资，致力于将斯坦福大学的发现转化为代谢健康的新纪元。

Post this

发布此内容

'GLP-1 therapies have fundamentally changed the landscape of weight management and metabolic health, but they haven't solved every challenge. There is a large and growing population of people who are tapering off treatment, cycling off, or who simply aren't candidates for GLP-1s and are seeking science-backed solutions that support long-term weight management.

GLP-1疗法从根本上改变了体重管理和代谢健康的格局，但并未解决所有挑战。目前，有庞大且日益增长的人群正在逐步减量停药、间歇性停药，或者根本不适合使用GLP-1药物，他们正在寻求有科学依据、能够支持长期体重管理的解决方案。

We founded Metabolize to translate groundbreaking research into innovative consumer products that address these unmet needs and ultimately help people live healthier lives,' said Dr. Morris Laster, founder and CEO of Metabolize..

“我们创立Metabolize，旨在将突破性研究成果转化为创新的消费产品，以满足这些未被满足的需求，并最终帮助人们过上更健康的生活。”Metabolize创始人兼首席执行官莫里斯·拉斯特博士表示。

The compounds targeted by Metabolize's research have defined biological functions supported by published scientific research. Metabolize translates these discoveries into consumer products with consistent composition and clearly defined mechanisms of action, creating a new category of metabolic health solutions built on Precision Metabolite™ Technology..

Metabolize 研究所针对的化合物具有经已发表科学研究证实的明确生物学功能。Metabolize 将这些发现转化为成分稳定、作用机制明确的消费级产品，从而开创了一个基于 Precision Metabolite™ 技术的代谢健康解决方案新品类。

Metabolize's first consumer product, NATLEAN, expected to launch in January 2027, is designed to support individuals transitioning off GLP-1 therapies by helping reduce food noise, support healthy appetite regulation and promote long-term weight management. NATLEAN represents the company's first commercial application of Precision Metabolite™ Technology, with additional products in development across its broader metabolic health portfolio..

Metabolize的首款消费者产品NATLEAN预计将于2027年1月推出，旨在通过帮助减少“食物噪音”、支持健康的食欲调节以及促进长期体重管理，来协助个体逐步停用GLP-1疗法。NATLEAN代表了该公司Precision Metabolite™技术的首次商业化应用，其更广泛的代谢健康产品组合中还有多款产品正在开发中。

'Metabolic health is one of the most significant and underserved challenges facing consumers today. At Astanor, we believe there is a growing need for science-backed solutions that complement existing approaches and help people achieve better long-term health. What stood out to us about Metabolize was the strength of the original research, the team's thoughtful approach to translating that science into consumer products, and their vision for building a new category in metabolic health.

代谢健康是当今消费者面临的最重大且尚未得到充分满足的挑战之一。在Astanor，我们相信，对于能够补充现有方法并帮助人们实现更好长期健康的、有科学依据的解决方案，需求正日益增长。Metabolize让我们印象深刻之处，在于其原创研究的实力、团队将科学成果转化为消费品的审慎 approach，以及他们在代谢健康领域开创全新品类的愿景。

We're excited to support Dr. Laster and team as they bring that vision to life,' said Christina Ulardic, Partner at Astanor..

“我们很高兴支持拉斯特博士及其团队将这一愿景变为现实，”Astanor 的合伙人克里斯蒂娜·乌拉迪奇表示。

About Metabolize

关于 Metabolize

Metabolize is a science-first consumer health company commercializing Precision Metabolite™ Technology developed from Stanford Medicine-originated research. The company develops metabolic health products based on naturally occurring compounds with defined biological roles, translating academic discoveries into consumer solutions designed to support metabolic health through consistent, research-based formulations.

Metabolize 是一家秉持科学优先理念的消费者健康公司，致力于将源自斯坦福医学院研究的 Precision Metabolite™ 技术商业化。该公司基于具有明确生物学作用的天然化合物开发代谢健康产品，将学术发现转化为消费者解决方案，通过始终如一、以研究为基础的配方支持代谢健康。

Since its founding, Metabolize has secured an exclusive license to Stanford Medicine-originated research, advanced its manufacturing and analytical capabilities and established the scientific foundation and IP portfolio for its Precision Metabolite™ Technology. Metabolize is Silicon Valley-backed with research and operations led from San Francisco, California.

自成立以来，Metabolize 已获得源自斯坦福医学院研究的独家许可，提升了其制造和分析能力，并为其 Precision Metabolite™ 技术奠定了科学基础并构建了知识产权组合。Metabolize 由硅谷支持，研发和运营总部设在加利福尼亚州旧金山。

For more information, visit .

更多信息，请访问。

metabolize.life

代谢。生命

About Astanor

关于 Astanor

Astanor is a global impact investment firm focused on seed through growth stage businesses across the entire agriculture and food value chain. Founded in 2017, Astanor counts circa 50 investments to date in Europe, North America and beyond. Astanor's mission is to invest in and support visionary entrepreneurs and management teams building scalable solutions for the transition to regenerative agriculture, sustainable food production, and resilient supply chains..

Astanor 是一家全球影响力投资机构，专注于农业和食品全产业链中从种子期到成长期的企业。自2017年成立以来，Astanor 迄今在欧洲、北美及其他地区已完成约50项投资。Astanor 的使命是投资并支持具有远见的企业家和管理团队，打造可扩展的解决方案，推动向再生农业、可持续食品生产和韧性供应链的转型。

SOURCE Metabolize

来源 代谢

21

二十一

%

百分比

more press release views with

更多新闻稿浏览量，借助

Request a Demo

申请演示